Literature DB >> 23065437

An update on antidepressant use in bipolar depression.

Michelle M Sidor1, Glenda M MacQueen.   

Abstract

The effective treatment of depression in people with bipolar disorder remains a clinical challenge. The role of antidepressant medication in treating bipolar depression has been controversial. While early studies and meta-analyses supported a role for antidepressant medication, more recent, high quality randomized controlled trials in bipolar depression have generally not demonstrated efficacy for antidepressant medications. Although the risk of affective switch and long-term de-stabilization remains a concern when using antidepressant medications in bipolar disorder, the magnitude of this risk has been difficult to ascertain with confidence. Maintenance use of antidepressant medication has generally not demonstrated a favorable risk-benefit ratio. Future studies should explore the patient characteristics and response patterns that predict a more favorable response profile to antidepressants amongst patients with bipolar disorder so that the medications can be rationally used in those who are most likely to benefit.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065437     DOI: 10.1007/s11920-012-0323-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  63 in total

1.  Risk factors for antidepressant-related switch to mania.

Authors:  Marc Valentí; Isabella Pacchiarotti; C Mar Bonnín; Adriane R Rosa; Dina Popovic; Alessandra M A Nivoli; José Manuel Goikolea; Andrea Murru; Juan Undurraga; Francesc Colom; Eduard Vieta
Journal:  J Clin Psychiatry       Date:  2012-02       Impact factor: 4.384

2.  Antidepressants in acute bipolar depression: an inconclusive meta-analysis.

Authors:  Nuria Cruz; Eduard Vieta
Journal:  J Clin Psychiatry       Date:  2011-03       Impact factor: 4.384

3.  Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double-blind study.

Authors:  M Bauer; R Zaninelli; B Müller-Oerlinghausen; W Meister
Journal:  J Clin Psychopharmacol       Date:  1999-04       Impact factor: 3.153

4.  The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.

Authors:  Heinz Grunze; Eduard Vieta; Guy M Goodwin; Charles Bowden; Rasmus W Licht; Hans-Jürgen Möller; Siegfried Kasper
Journal:  World J Biol Psychiatry       Date:  2010-03       Impact factor: 4.132

5.  Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.

Authors:  Jay D Amsterdam; Justine Shults
Journal:  J Affect Disord       Date:  2005-07       Impact factor: 4.839

6.  Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.

Authors:  Gabriele S Leverich; Lori L Altshuler; Mark A Frye; Trisha Suppes; Susan L McElroy; Paul E Keck; Ralph W Kupka; Kirk D Denicoff; Willem A Nolen; Heinz Grunze; Maria I Martinez; Robert M Post
Journal:  Am J Psychiatry       Date:  2006-02       Impact factor: 18.112

7.  A practical approach to the early identification of antidepressant medication non-responders.

Authors:  J Li; A Y C Kuk; A J Rush
Journal:  Psychol Med       Date:  2011-07-25       Impact factor: 7.723

8.  Transition to mania during treatment of bipolar depression.

Authors:  Roy H Perlis; Michael J Ostacher; Joseph F Goldberg; David J Miklowitz; Edward Friedman; Joseph Calabrese; Michael E Thase; Gary S Sachs
Journal:  Neuropsychopharmacology       Date:  2010-09-08       Impact factor: 7.853

9.  Risperidone and paroxetine given singly and in combination for bipolar depression.

Authors:  Richard C Shelton; Stephen M Stahl
Journal:  J Clin Psychiatry       Date:  2004-12       Impact factor: 4.384

10.  SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study.

Authors:  Gordon Parker; Lucy Tully; Amanda Olley; Dusan Hadzi-Pavlovic
Journal:  J Affect Disord       Date:  2006-03-03       Impact factor: 4.839

View more
  16 in total

Review 1.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

2.  Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis.

Authors:  Shengjun Wang; Zhigang Zhang; Li Yao; Nannan Ding; Lingjie Jiang; Yuchen Wu
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

Review 3.  The difficult lives of individuals with bipolar disorder: A review of functional outcomes and their implications for treatment.

Authors:  Michael J Gitlin; David J Miklowitz
Journal:  J Affect Disord       Date:  2016-11-22       Impact factor: 4.839

4.  Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients.

Authors:  Antonio Drago; Barbara Monti; Diana De Ronchi; Alessandro Serretti
Journal:  Neuropsychobiology       Date:  2014-02-27       Impact factor: 2.328

Review 5.  Treatment of bipolar disorder.

Authors:  John R Geddes; David J Miklowitz
Journal:  Lancet       Date:  2013-05-11       Impact factor: 79.321

Review 6.  Pharmacological treatment of adult bipolar disorder.

Authors:  Ross J Baldessarini; Leonardo Tondo; Gustavo H Vázquez
Journal:  Mol Psychiatry       Date:  2018-04-20       Impact factor: 15.992

7.  Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study).

Authors:  Young-Min Park; Bun-Hee Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-17       Impact factor: 2.570

8.  Daytime spikes in dopaminergic activity drive rapid mood-cycling in mice.

Authors:  M M Sidor; S M Spencer; K Dzirasa; P K Parekh; K M Tye; M R Warden; R N Arey; J F Enwright; J P R Jacobsen; S Kumar; E M Remillard; M G Caron; K Deisseroth; C A McClung
Journal:  Mol Psychiatry       Date:  2015-01-06       Impact factor: 15.992

9.  Lamotrigine Therapy for Bipolar Depression: Analysis of Self-Reported Patient Data.

Authors:  Antoine Nzeyimana; Kate Ea Saunders; John R Geddes; Patrick E McSharry
Journal:  JMIR Ment Health       Date:  2018-11-22

Review 10.  Antidepressants in bipolar depression: an enduring controversy.

Authors:  Michael J Gitlin
Journal:  Int J Bipolar Disord       Date:  2018-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.